The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Open accessAbstract
In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G) complement plays a primary role in disease pathogenesis. Herein we report the outcome of a 2015 Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference where key issues in the management of these 2 diseases were considered by a global panel of experts. Areas addressed included renal pathology, clinical phenotype and assessment, genetic drivers of disease, acquired drivers of disease, and treatment strategies. In order to help guide clinicians who are caring for such patients, recommendations for best treatment strategies were discussed at length, providing the evidence base underpinning current treatment options. Knowledge gaps were identified and a prioritized research agenda was proposed to resolve outstanding controversial issues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Legendre, C. M., Licht, C., Muus, P., Greenbaum, L. A., Babu, S., Bedrosian, C., Bingham, C., Cohen, D. J., Delmas, Y., Douglas, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208981 · Cited by 1,586
Self-citationAtypical Hemolytic–Uremic Syndrome
Noris, M., & Remuzzi, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902814 · Cited by 1,338
Self-citationA Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran, D. C., Coppo, R., Cook, H. T., Feehally, J., Roberts, I. S. D., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., et al. (2009) · Kidney International · doi:10.1038/ki.2009.243 · Cited by 1,235
Self-citationNoris, M., Caprioli, J., Bresin, E., Mossali, C., Pianetti, G., Gamba, S., Daina, E., Fenili, C., Castelletti, F., Sorosina, A., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02210310 · Cited by 1,042
Self-citationA Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts, I. S. D., Cook, H. T., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., Berthoux, F., Bonsib, S., Bruijn, J. A., et al. (2009) · Kidney International · doi:10.1038/ki.2009.168 · Cited by 1,038
Self-citationSeven new loci associated with age-related macular degeneration
The AMD Gene Consortium (2013) · Nature Genetics · doi:10.1038/ng.2578 · Cited by 788
Caprioli, J., Noris, M., Brioschi, S., Pianetti, G., Castelletti, F., Bettinaglio, P., Mele, C., Bresin, E., Cassis, L., Gamba, S., et al. (2006) · Blood · doi:10.1182/blood-2005-10-007252 · Cited by 732
Self-citationFremeaux-Bacchi, V., Fakhouri, F., Garnier, A., Bienaimé, F., Dragon-Durey, M.-A., Ngo, S., Moulin, B., Servais, A., Provot, F., Rostaing, L., et al. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04760512 · Cited by 714
Self-citationC3 glomerulopathy: consensus report
Pickering, M. C., D'Agati, V. D., Nester, C. M., Smith, R. J., Haas, M., Appel, G. B., Alpers, C. E., Bajema, I. M., Bedrosian, C., Braun, M., et al. (2013) · Kidney International · doi:10.1038/ki.2013.377 · Cited by 653
Self-citationNoris, M., & Remuzzi, G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100861 · Cited by 635
Self-citationInternational, F. H., Loirat, C., Fakhouri, F., Ariceta, G., Besbas, N., Bitzan, M., Bjerre, A., Coppo, R., Emma, F., Johnson, S., et al. (2016) · Pediatric Nephrology · doi:10.1007/s00467-015-3076-8 · Cited by 596
Self-citationServais, A., Noël, L.-H., Roumenina, L. T., Le Quintrec, M., Ngo, S., Dragon-Durey, M.-A., Macher, M.-A., Zuber, J., Karras, A., Provot, F., et al. (2012) · Kidney International · doi:10.1038/ki.2012.63 · Cited by 575
Self-citationThrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome
Delvaeye, M., Noris, M., De Vriese, A., Esmon, C. T., Esmon, N. L., Ferrell, G., Del-Favero, J., Plaisance, S., Claes, B., Lambrechts, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810739 · Cited by 554
Self-citationUse of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
on behalf of the French Study Group for aHUS/C3G, Zuber, J., Fakhouri, F., Roumenina, L. T., Loirat, C., & Frémeaux-Bacchi, V. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.214 · Cited by 496
Self-citationRecessive mutations in DGKE cause atypical hemolytic-uremic syndrome
Lemaire, M., Frémeaux-Bacchi, V., Schaefer, F., Choi, M., Tang, W. H., Le Quintrec, M., Fakhouri, F., Taque, S., Nobili, F., Martinez, F., et al. (2013) · Nature Genetics · doi:10.1038/ng.2590 · Cited by 483
Self-citationde Jorge, E. G., Harris, C. L., Esparza-Gordillo, J., Carreras, L., Arranz, E. A., Garrido, C. A., López-Trascasa, M., Sánchez-Corral, P., Morgan, B. P., & de Córdoba, S. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603420103 · Cited by 447
Self-citationLicht, C., Greenbaum, L. A., Muus, P., Babu, S., Bedrosian, C. L., Cohen, D. J., Delmas, Y., Douglas, K., Furman, R. R., Gaber, O. A., et al. (2015) · Kidney International · doi:10.1038/ki.2014.423 · Cited by 420
Self-citationRichards, A., Kemp, E. J., Liszewski, M. K., Goodship, J. A., Lampe, A. K., Decorte, R., Müslümanogğlu, M. H., Kavukcu, S., Filler, G., Pirson, Y., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135497100 · Cited by 405
Self-citationEculizumab for Dense Deposit Disease and C3 Glomerulonephritis
Bomback, A. S., Smith, R. J., Barile, G. R., Zhang, Y., Heher, E. C., Herlitz, L., Stokes, M. B., Markowitz, G. S., D’Agati, V. D., Canetta, P. A., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12901211 · Cited by 366
Self-citationGerber, A., Karch, H., Allerberger, F., Verweyen, H. M., & Zimmerhackl, L. B. (2002) · The Journal of Infectious Diseases · doi:10.1086/341940 · Cited by 363
Bresin, E., Rurali, E., Caprioli, J., Sanchez-Corral, P., Fremeaux-Bacchi, V., Rodriguez de Cordoba, S., Pinto, S., Goodship, T. H. J., Alberti, M., Ribes, D., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012090884 · Cited by 352
Self-citationManuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P. H., Remuzzi, G., & Zipfel, P. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16651 · Cited by 350
Self-citationAtypical Hemolytic Uremic Syndrome
Kavanagh, D., Goodship, T. H., & Richards, A. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.003 · Cited by 348
Self-citationDynamics of complement activation in aHUS and how to monitor eculizumab therapy
Noris, M., Galbusera, M., Gastoldi, S., Macor, P., Banterla, F., Bresin, E., Tripodo, C., Bettoni, S., Donadelli, R., Valoti, E., et al. (2014) · Blood · doi:10.1182/blood-2014-02-558296 · Cited by 341
Self-citationGale, D. P., de Jorge, E. G., Cook, H. T., Martinez-Barricarte, R., Hadjisavvas, A., McLean, A. G., Pusey, C. D., Pierides, A., Kyriacou, K., Athanasiou, Y., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60670-8 · Cited by 327
Self-citationMaga, T. K., Nishimura, C. J., Weaver, A. E., Frees, K. L., & Smith, R. J. H. (2010) · Human Mutation · doi:10.1002/humu.21256 · Cited by 308
Self-citationCaprioli, J., Castelletti, F., Bucchioni, S., Bettinaglio, P., Bresin, E., Pianetti, G., Gamba, S., Brioschi, S., Daina, E., Remuzzi, G., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg363 · Cited by 306
Self-citationSethi, S., Fervenza, F. C., Zhang, Y., Zand, L., Vrana, J. A., Nasr, S. H., Theis, J. D., Dogan, A., & Smith, R. J. H. (2012) · Kidney International · doi:10.1038/ki.2012.212 · Cited by 299
Self-citationPérez-Caballero, D., González-Rubio, C., Gallardo, M. E., Vera, M., López-Trascasa, M., Rodríguez de Córdoba, S., & Sánchez-Corral, P. (2001) · The American Journal of Human Genetics · doi:10.1086/318201 · Cited by 293
Self-citationThe MEST score provides earlier risk prediction in lgA nephropathy
Barbour, S. J., Espino-Hernandez, G., Reich, H. N., Coppo, R., Roberts, I. S. D., Feehally, J., Herzenberg, A. M., Cattran, D. C., Bavbek, N., Cook, T., et al. (2016) · Kidney International · doi:10.1038/ki.2015.322 · Cited by 292
Self-citationDimerization of complement factor H-related proteins modulates complement activation in vivo
Goicoechea de Jorge, E., Caesar, J. J. E., Malik, T. H., Patel, M., Colledge, M., Johnson, S., Hakobyan, S., Morgan, B. P., Harris, C. L., Pickering, M. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219260110 · Cited by 289
Self-citationMisra, A., Peethambaram, A., & Garg, A. (2004) · Medicine · doi:10.1097/01.md.0000111061.69212.59 · Cited by 285
Esparza-Gordillo, J., Jorge, E. G. D., Buil, A., Berges, L. C., López-Trascasa, M., Sánchez-Corral, P., & Córdoba, S. R. D. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi066 · Cited by 281
Pickering, M. C., de Jorge, E. G., Martinez-Barricarte, R., Recalde, S., Garcia-Layana, A., Rose, K. L., Moss, J., Walport, M. J., Cook, H. T., de Córdoba, S. R., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070301 · Cited by 278
Self-citationComplement activation by heme as a secondary hit for atypical hemolytic uremic syndrome
Frimat, M., Tabarin, F., Dimitrov, J. D., Poitou, C., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2013) · Blood · doi:10.1182/blood-2013-03-489245 · Cited by 249
Self-citationMartínez-Barricarte, R., Heurich, M., Valdes-Cañedo, F., Vazquez-Martul, E., Torreira, E., Montes, T., Tortajada, A., Pinto, S., Lopez-Trascasa, M., Morgan, B. P., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43343 · Cited by 222
Self-citationSánchez-Corral, P., Pérez-Caballero, D., Huarte, O., Simckes, A. M., Goicoechea, E., López-Trascasa, M., & de Córdoba, S. R. (2002) · The American Journal of Human Genetics · doi:10.1086/344515 · Cited by 218
Abarrategui-Garrido, C., Martínez-Barricarte, R., López-Trascasa, M., Rodríguez de Córdoba, S., & Sánchez-Corral, P. (2009) · Blood · doi:10.1182/blood-2009-05-223834 · Cited by 206
Self-citationLicht, C., Heinen, S., Józsi, M., Löschmann, I., Saunders, R. E., Perkins, S. J., Waldherr, R., Skerka, C., Kirschfink, M., Hoppe, B., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000269 · Cited by 205
Self-citationToward a working definition of C3 glomerulopathy by immunofluorescence
Hou, J., Markowitz, G. S., Bomback, A. S., Appel, G. B., Herlitz, L. C., Barry Stokes, M., & D'Agati, V. D. (2014) · Kidney International · doi:10.1038/ki.2013.340 · Cited by 203
Self-citationArdissino, G., Testa, S., Possenti, I., Tel, F., Paglialonga, F., Salardi, S., Tedeschi, S., Belingheri, M., & Cugno, M. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.01.434 · Cited by 201
Self-citationSethi, S., Gamez, J. D., Vrana, J. A., Theis, J. D., Robert Bergen, H., Zipfel, P. F., Dogan, A., & Smith, R. J. H. (2009) · Kidney International · doi:10.1038/ki.2008.657 · Cited by 200
Self-citationC3 glomerulopathy–associated CFHR1 mutation alters FHR oligomerization and complement regulation
Tortajada, A., Yébenes, H., Abarrategui-Garrido, C., Anter, J., García-Fernández, J. M., Martínez-Barricarte, R., Alba-Domínguez, M., Malik, T. H., Bedoya, R., Pérez, R. C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68280 · Cited by 197
Self-citationAtypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene
Venables, J. P., Strain, L., Routledge, D., Bourn, D., Powell, H. M., Warwicker, P., Diaz-Torres, M. L., Sampson, A., Mead, P., Webb, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030431 · Cited by 195
Self-citationEffectiveness of mycophenolate mofetil in C3 glomerulonephritis
Rabasco, C., Cavero, T., Román, E., Rojas-Rivera, J., Olea, T., Espinosa, M., Cabello, V., Fernández-Juarez, G., González, F., Ávila, A., et al. (2015) · Kidney International · doi:10.1038/ki.2015.227 · Cited by 170
Self-citationH deficiency in two brothers with atypical dense intramembranous deposit disease
Levy, M., Halbwachs–Mecarelli, L., Gubler, M., Kohout, G., Bensenouci, A., Niaudet, P., Hauptmann, G., & Lesavre, P. (1986) · Kidney International · doi:10.1038/ki.1986.278 · Cited by 169
The complotype: dictating risk for inflammation and infection
Harris, C. L., Heurich, M., Cordoba, S. R. D., & Morgan, B. P. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.06.001 · Cited by 163
Self-citationAult, B. H., Schmidt, B. Z., Fowler, N. L., Kashtan, C. E., Ahmed, A. E., Vogt, B. A., & Colten, H. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25168 · Cited by 159
Roumenina, L. T., Jablonski, M., Hue, C., et al. (2009) · Blood · doi:10.1182/blood-2009-01-197640 · Cited by 157
Self-citationPathology after Eculizumab in Dense Deposit Disease and C3 GN
Herlitz, L., Bomback, A. S., Markowitz, G. S., Stokes, M. B., Smith, R. N., Colvin, R. B., Appel, G. B., & D’Agati, V. D. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011121186 · Cited by 155
Self-citationMcCaughan, J. A., O’Rourke, D. M., & Courtney, A. E. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03923.x · Cited by 149
Schramm, E. C., Roumenina, L. T., Robe-Rybkine, T., Chauvet, S., Vieira-Martins, P., Hue, C., Maga, T., Valoti, E., Wilson, V., Jokiranta, S. T., et al. (2015) · Blood · doi:10.1182/blood-2014-10-609073 · Cited by 143
Self-citationStåhl, A.-L., Vaziri‐Sani, F., Heinen, S., Kristoffersson, A., GYDELL, K., Raafat, R. H., Gutiérrez, A., Beringer, O., Zipfel, P. F., & Karpman, D. (2008) · Blood · doi:10.1182/blood-2007-08-106153 · Cited by 139
Self-citationMembranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits
Larsen, C. P., Messias, N. C., Walker, P. D., et al. (2015) · Kidney International · doi:10.1038/ki.2015.195 · Cited by 138
Kavanagh, D., Yu, Y., Schramm, E. C., Triebwasser, M. P., Wagner, E. K., Raychaudhuri, S., Daly, M. J., Atkinson, J. P., & Seddon, J. M. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv091 · Cited by 137
Self-citationTarshish, P., Bernstein, J., Tobin, J. N., et al. (1992) · Pediatric Nephrology · doi:10.1007/bf00866289 · Cited by 136
Duvall-Young, J., MacDonald, M. K., & McKechnie, N. M. (1989) · British Journal of Ophthalmology · doi:10.1136/bjo.73.4.297 · Cited by 124
Complement-mediated adipocyte lysis by nephritic factor sera.
Mathieson, P. W., Würzner, R., Oliveria, D. B., Lachmann, P. J., & Peters, D. K. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.6.1827 · Cited by 122
High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies
Bu, F., Borsa, N. G., Jones, M. B., Takanami, E., Nishimura, C. J., Hauer, J. J., Azaiez, H., Black-Ziegelbein, E. A., Meyer, N. C., Kolbe, D. L., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015040385 · Cited by 118
Self-citationComplement Factor B Mutations in Atypical Hemolytic Uremic Syndrome—Disease-Relevant or Benign?
Marinozzi, M. C., Vergoz, L., Robe-Rybkine, T., Ngo, S., Bettoni, S., Pashov, A. D., Cayla, M., Tabarin, F., Jablonski, M., Hue, C., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070796 · Cited by 116
Self-citationYu, Y., Triebwasser, M. P., Wong, E. K. S., Schramm, E. C., Thomas, B., Reynolds, R. C., Mardis, E. R., Atkinson, J. P., Daly, M. J., Raychaudhuri, S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu226 · Cited by 112
Self-citationComplement factor H–related hybrid protein deregulates complement in dense deposit disease
Chen, Q., Wiesener, M. S., Eberhardt, H. U., Hartmann, A., Uzonyi, B., Kirschfink, M., Amann, K., Buettner, M., Goodship, T. H. J., Hugo, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71866 · Cited by 110
Self-citationEculizumab for Treatment of Rapidly Progressive C3 Glomerulopathy
Quintrec, M. L., Lionet, A., Kandel, C., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.09.025 · Cited by 108
Vernon, K. A., de Jorge, E. G., Hall, A. E., Frémeaux‐Bacchi, V., Aitman, T. J., Cook, H. T., Hangartner, R., Koziell, A. B., & Pickering, M. C. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.02.329 · Cited by 98
Self-citationAllelic Variants of Complement Genes Associated with Dense Deposit Disease
Abrera-Abeleda, M. A., Nishimura, C. J., Frees, K. L., Jones, M. P., Maga, T., Katz, L. M., Zhang, Y., & Smith, R. J. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080795 · Cited by 96
Self-citationSheerin, N., Kavanagh, D., Goodship, T. H. J., et al. (2015) · QJM · doi:10.1093/qjmed/hcv082 · Cited by 95
Self-citationValoti, E., Alberti, M., Tortajada, A., García-Fernández, J., Gastoldi, S., Besso, L., Bresin, E., Remuzzi, G., de Córdoba, S. R., & Noris, M. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121339 · Cited by 94
Self-citationDiagnosis of complement alternative pathway disorders
Angioi, A., Fervenza, F. C., Sethi, S. M., Zhang, Y., Smith, R. J., Murray, D. L., Praet, J. T. V., Pani, A., & Vriese, A. S. D. (2016) · Kidney International · doi:10.1016/j.kint.2015.12.003 · Cited by 88
Self-citationComplement Factor H Autoantibodies Are Associated with Early Stage NSCLC
Amornsiripanitch, N., Hong, S.-L., Campa, M. J., Frank, M. M., Gottlin, E. B., & Patz, E. F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0321 · Cited by 76
Complement Mutations in Diacylglycerol Kinase-ε–Associated Atypical Hemolytic Uremic Syndrome
Chinchilla, D. S., Pinto, S., Höppe, B., Adragna, M. S., Lopez, L., Roldán, M. L. J., Peña, A., López‐Trascasa, M., Sánchez‐Corral, P., & de Córdoba, S. R. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01640214 · Cited by 72
Rituximab fails where eculizumab restores renal function in C3nef-related DDD
Rousset‐Rouvière, C., Cailliez, M., Garaix, F., et al. (2014) · Pediatric Nephrology · doi:10.1007/s00467-013-2711-5 · Cited by 67
Bernabeu-Herrero, M. E., Jiménez-Alcázar, M., Anter, J., Pinto, S., Chinchilla, D. S., Garrido, S., López‐Trascasa, M., de Córdoba, S. R., & Sánchez‐Corral, P. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.06.021 · Cited by 63
Barbour, T., Ruseva, M. M., & Pickering, M. C. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu317 · Cited by 55
Self-citationChauvet, S., Roumenina, L. T., Bruneau, S., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015040348 · Cited by 49
Self-citationMontes, T., Goicoechea de Jorge, E., Ramos, R., Gomà, M., Pujol, O., Sánchez-Corral, P., & Rodríguez de Córdoba, S. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.01.027 · Cited by 47
Wong, E. K. S., Anderson, H. E., Herbert, A. P., Challis, R. C., Brown, P., dos Reis, G. S., Tellez, J. O., Strain, L., Fluck, N., Humphrey, A., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070732 · Cited by 43
Self-citationChallis, R. C., Araujo, G. S. R., Wong, E. K. S., Anderson, H. E., Awan, A., Dorman, A. M., Waldron, M., Wilson, V., Brocklebank, V., Strain, L., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015010100 · Cited by 41
Self-citationEculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis
Inman, M., Prater, G. L., Fatima, H., et al. (2015) · Clinical Kidney Journal · doi:10.1093/ckj/sfv044 · Cited by 36
A novel CFHR5 mutation associated with C3 glomerulonephritis in a Turkish girl
Beşbaş, N., Gülhan, B., Güçer, Ş., et al. (2013) · Journal of Nephrology · doi:10.1007/s40620-013-0008-1 · Cited by 33
Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases
Recalde, S., Tortajada, A., Subias, M., Anter, J., Blasco, M., Maranta, R., Coco, R., Pinto, S., Noris, M., García-Layana, A., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050580 · Cited by 32
Self-citationLiver transplantation for aHUS: still needed in the eculizumab era?
Coppo, R., Bonaudo, R., Peruzzi, L., Amore, A., Brunati, A., Romagnoli, R., Salizzoni, M., Galbusera, M., Gotti, E., Daina, E., et al. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3278-0 · Cited by 30
Self-citationSchejbel, L., Schmidt, I. M., Kirchhoff, M., Andersen, C. B., Marquart, H. V., Zipfel, P. F., & Garred, P. (2011) · Genes and Immunity · doi:10.1038/gene.2010.63 · Cited by 29
Self-citationFactors determining penetrance in familial atypical haemolytic uraemic syndrome
Sansbury, F. H., Cordell, H. J., Bingham, C., Bromilow, G., Nicholls, A., Powell, R. J., Shields, B. M., Smyth, L., Warwicker, P., Strain, L., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102498 · Cited by 28
Self-citationde Córdoba, S. R. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.05.015 · Cited by 27
Dalvin, L. A., Fervenza, F. C., Sethi, S. M., & Pulido, J. S. (2015) · Retinal Cases & Brief Reports · doi:10.1097/icb.0000000000000164 · Cited by 27
Self-citation
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Self-citationKDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Rovin, B. H., Ayoub, I. M., Chan, T. M., Liu, Z.-H., Mejía-Vilet, J. M., & Floege, J. (2024) · Kidney International · doi:10.1016/j.kint.2023.09.002 · Cited by 517
C3 glomerulopathy — understanding a rare complement-driven renal disease
Smith, R. J. H., Appel, G. B., Blom, A. M., Cook, H. T., D’Agati, V. D., Fakhouri, F., Fremeaux-Bacchi, V., Józsi, M., Kavanagh, D., Lambris, J. D., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0107-2 · Cited by 409
Self-citationThrombotic Microangiopathy and the Kidney
Brocklebank, V., Wood, K. M., & Kavanagh, D. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00620117 · Cited by 373
Self-citationRegulation of regulators: Role of the complement factor H-related proteins
Cserhalmi, M., Papp, A., Brandus, B., Uzonyi, B., & Józsi, M. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101341 · Cited by 131
Self-citation
Metadata
- Authors
- Goodship, T. H. J., Cook, H. T., Fakhouri, F., Fervenza, F. C., Frémeaux-Bacchi, V., Kavanagh, D., Nester, C. M., Noris, M., Pickering, M. C., Rodríguez de Córdoba, S., Roumenina, L. T., Sethi, S., Smith, R. J. H., Alpers, C. E., Appel, G. B., Ardissino, G., Ariceta, G., Arici, M., Bagga, A., Bajema, I. M., Blasco, M., Burke, L., Cairns, T. D., Carratala, M., D'Agati, V. D., Daha, M. R., De Vriese, A. S., Dragon-Durey, M.-A., Fogo, A. B., Galbusera, M., Gale, D. P., Haller, H., Johnson, S., Józsi, M., Karpman, D., Lanning, L., Le Quintrec, M., Licht, C., Loirat, C., Monfort, F., Morgan, B. P., Noël, L.-H., O'Shaughnessy, M. M., Rabant, M., Rondeau, E., Ruggenenti, P., Sheerin, N. S., Smith, J., Spoleti, F., Thurman, J. M., van de Kar, N. C. A. J., Vivarelli, M., & Zipfel, P. F.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 91
- Issue
- 3
- Pages
- 539-551
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2565152113
- Cited by
- 701
- References
- 86
- FWCI
- 28.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.